Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Coloplast Director's Dealing 2022

Sep 14, 2022

3358_rpt_2022-09-14_941c5a46-13e1-4aed-a8fc-9c6632987dc1.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Coloplast A/S Holtedam 1 3050 Humlebaek Denmark Tel: +45 4911 1111 www.coloplast.com Company reg. (CVR) no. 69749917

Report on transactions of executives and related parties in Coloplast shares and related securities

According to the Market Abuse Regulation article 19 Coloplast is obliged to report on the transactions of executives and their related parties in Coloplast shares and related securities.

The below transaction concerns the exercise of share options.

1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Anders Lonning-Skovgaard
2 Reason for the notification
a) Position/status Executive Vice President, CFO
b) Initial notification/Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Coloplast A/S (CVR-no.: 69749917)
b) LEI code 529900NN7SOJ5QG82X67
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii)
each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Share options
Identification code NA
b) Nature of the transaction Exercise of share options (cash settlement)
c) Price(s) and volume(s) Price(s) Volume(s)
497.30 38,939
d) Aggregated information
- Aggregated volume 38,939 share options
- Price DKK 497.30 (exercise price)
DKK 910.40 (share price)
e) Date of the transaction 2022-09-13, 10:38:06 UTC (exercise carried out)
f) Place of the transaction Outside a trading venue

Our mission

Making life easier for people with intimate health care needs

Our values

Closeness... to better understand Passion... to make a difference Respect and responsibility... to guide us

Our vision

Setting the global standard for listening and responding

For further information, please contact

Investors and analysts Press and media Address

Anders Lonning-Skovgaard Executive Vice President, CFO Tel. +45 4911 1111

Aleksandra Dimovska Director, Investor Relations Tel. +45 4911 1800 / +45 4911 2458 Email: [email protected]

Kristine Husted Munk Sr. Manager, Investor Relations Tel. +45 4911 1800 / +45 4911 3266 Email: [email protected]

Peter Mønster Sr. Media Relations Manager Tel. +45 4911 2623 Email: [email protected]

Coloplast A/S Holtedam 1 DK-3050 Humlebaek Denmark Company reg. (CVR) no. 69749917

Website

www.coloplast.com

This announcement is available in a Danish and an English-language version. In the event of discrepancies, the Danish version shall prevail.

Coloplast develops products and services that make life easier for people with very personal and private medical conditions. Working closely with the people who use our products, we create solutions that are sensitive to their special needs. We call this intimate health care. Our business includes Ostomy Care, Continence Care, Wound and Skin Care and Interventional Urology and Voice & Respiratory Care. We operate globally and employ about 14,000 employees.

The Coloplast logo is a registered trademark of Coloplast A/S. © 2022-09. All rights reserved Coloplast A/S, 3050 Humlebaek, Denmark.